Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANGELS: Effects of anagliptin on blood lipids in type 2 diabetes
jRCTs041180085Completed
- Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of anagliptin in type 2 diabetes mellitus (T2DM) and dyslipidemia (2 arms), sponsored by Sanwa Kagaku Kenkyusho Co., Ltd. Primary endpoint: Blood lipid fractions. Started Jul 2014; status: completed.
02
Drugs
anagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)dyslipidemia
Beyond the preview
Go deeper on jRCTs041180085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180085.